Home » Stocks » Regeneron Pharmaceuticals » Financials » Income Statement

Regeneron Pharmaceuticals, Inc. (REGN)

Stock Price: $565.00 USD -4.15 (-0.73%)
Updated Sep 17, 2020 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue7,8636,7115,8724,8604,1042,8202,1051,37844645937923812563.4566.1917457.5021.9921.9759.2834.5038.3333.1024.1127.38
Revenue Growth17.18%14.28%20.82%18.44%45.55%33.96%52.69%209.2%-2.89%21.04%59.05%90.73%97.05%-4.15%-61.96%202.65%161.49%0.07%-62.93%71.82%-9.99%15.79%37.26%-11.94%-
Cost of Revenue78243439730039320515584.464.222.091.690.92-8.159.5615.216.686.486.5115.573.615.002.621.120.07
Gross Profit7,0816,2775,4754,5613,7112,6151,9491,29444245737823812555.3056.6415950.8215.5115.4643.7130.8933.3330.4823.0027.31
Selling, General & Admin1,8351,5561,3201,17883951934621111765.2052.9248.8837.9325.8925.4817.0614.7912.539.618.436.435.845.775.885.76
Research & Development3,0372,1862,0752,0521,6211,27186062653048939927520213715613613612592.5460.5648.2937.0527.7728.2723.31
Other Operating Expenses0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.003.024.396.086.74
Operating Expenses4,8713,7423,3963,2302,4591,7911,20683664755445232424016318115315113710268.9954.7245.9037.9240.2335.81
Operating Income2,2102,5342,0801,3311,252824743458-205-97.47-74.10-86.25-115-108-1245.65-99.99-122-86.69-25.28-23.83-12.58-7.44-17.23-8.50
Interest Expense / Income30.2028.2025.107.2014.2437.3746.4445.3021.289.122.347.7512.0412.0412.0512.1811.9311.862.660.280.280.430.740.941.20
Other Expense / Income-250-47.30-24.00-6.3012.5825.310.23-2.01-3.55-2.12-4.49-17.22-20.90-17.36-41.02-48.23-4.46-9.46-13.16-2.34-1.05-4.383.4014.2513.80
Pretax Income2,4292,5542,0791,3301,225761696414-223-104-71.95-76.78-107-102-95.4541.70-107-124-76.18-23.22-23.07-8.63-11.58-32.42-23.51
Income Tax313109880434589423283-336-1.13--4.122.35-------------
Net Income2,1162,4441,199896636338414750-222-104-67.83-79.13-107-102-95.4541.70-107-124-76.18-23.22-23.07-8.63-11.58-32.42-23.51
Shares Outstanding (Basic)10910810610510310197.9294.6990.6182.9379.7878.8366.3357.9755.9555.4250.4944.0443.7336.7631.3331.0230.93--
Shares Outstanding (Diluted)11511511611611511311111590.6182.9379.7878.8366.3357.9755.9556.1750.49--------
Shares Change1.2%1.51%1.53%1.59%2.43%2.75%3.41%4.5%9.27%3.94%1.21%18.83%14.43%3.61%0.96%9.76%14.66%0.69%18.97%17.35%1%0.28%---
EPS (Basic)19.3822.6511.278.556.173.364.237.92-2.45-1.26-0.85-1.00-1.61-1.77-1.710.75-2.13-2.83-1.81-0.66-0.74-0.28-0.40-1.33-1.19
EPS (Diluted)18.4621.2910.347.705.522.983.726.75-2.45-1.26-0.85-1.00-1.61-1.77-1.710.74-2.13-2.83-1.81-0.66-0.74-0.28-0.40-1.33-1.19
EPS Growth-13.29%105.9%34.29%39.49%85.23%-19.89%-44.89%------------------
Free Cash Flow Per Share18.3216.799.739.306.344.174.42-1.31-2.20-0.01-2.10-1.570.140.35-0.63-0.42-0.71-3.29-1.50-0.94-0.61-0.43-0.56--
Gross Margin90.1%93.5%93.2%93.8%90.4%92.7%92.6%93.9%99.1%99.5%99.6%99.6%100%87.2%85.6%91.3%88.4%70.5%70.4%73.7%89.5%86.9%92.1%95.4%99.7%
Operating Margin28.1%37.8%35.4%27.4%30.5%29.2%35.3%33.2%-46.0%-21.2%-19.5%-36.2%-92.3%-169.7%-188.0%3.2%-173.9%-554.8%-394.5%-42.6%-69.1%-32.8%-22.5%-71.5%-31.0%
Profit Margin26.9%36.4%20.4%18.4%15.5%12%19.7%54.4%-49.7%-22.8%-17.9%-33.2%-85.2%-161.3%-144.2%24%-186.9%-565.7%-346.7%-39.2%-66.9%-22.5%-35%-134.5%-85.8%
FCF Margin25.4%27.0%17.6%20.0%15.9%14.9%20.5%-9.0%-44.6%-0.1%-44.1%-52.0%7.1%31.9%-53.3%-13.3%-62.2%-659.0%-298.3%-58.0%-55.6%-34.6%-52.0%-119.9%-78.8%
Effective Tax Rate12.9%4.3%42.3%32.7%48.1%55.6%40.6%------------------
EBITDA2,6702,7302,2491,4421,314851784497-171-75.66-55.37-57.74-82.99-75.70-67.9069.24-82.59-104-67.45-18.51-19.36-5.18-10.84-25.40-16.40
EBITDA Margin33.9%40.7%38.3%29.7%32%30.2%37.3%36%-38.3%-16.5%-14.6%-24.2%-66.4%-119.3%-102.6%39.8%-143.6%-473.3%-306.9%-31.2%-56.1%-13.5%-32.8%-105.3%-59.9%
EBIT2,4592,5822,1041,3371,239799743460-202-95.35-69.62-69.03-94.48-90.29-83.4053.87-95.53-113-73.52-22.93-22.79-8.20-10.84-31.48-22.30
EBIT Margin31.3%38.5%35.8%27.5%30.2%28.3%35.3%33.4%-45.2%-20.8%-18.4%-28.9%-75.6%-142.3%-126.0%31.0%-166.1%-511.7%-334.6%-38.7%-66.0%-21.4%-32.8%-130.6%-81.4%